Protein and peptide parenteral controlled delivery

Rajendra Pawar, Alon Ben-Ari, Abraham J. Domb

Research output: Contribution to journalReview article

45 Citations (Scopus)

Abstract

Protein and peptide delivery has been a challenge due to their limited stability during preparation of formulation, storage and in vitro and in vivo release. These biopolymers have traditionally been administered via intramuscular or subcutaneous routes. Recent efforts have been made to develop formulations for non-invasive routes of administration, including oral, intranasal, transdermal and transmucosal delivery. Despite these efforts, invasive delivery remains the main method of administering peptide and protein drugs. This review focuses on recent developments in injectable, polymeric controlled-release formulations, with an emphasis on hydrogels and particulate systems.

Original languageEnglish (US)
Pages (from-to)1203-1212
Number of pages10
JournalExpert Opinion on Biological Therapy
Volume4
Issue number8
DOIs
StatePublished - Aug 1 2004
Externally publishedYes

Fingerprint

Peptides
Biopolymers
Hydrogels
Oral Administration
Proteins
Injections
Pharmaceutical Preparations
In Vitro Techniques

Keywords

  • Controlled-release
  • Injectable particles
  • Invasive delivery
  • Peptide delivery
  • Protein delivery

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery
  • Clinical Biochemistry

Cite this

Protein and peptide parenteral controlled delivery. / Pawar, Rajendra; Ben-Ari, Alon; Domb, Abraham J.

In: Expert Opinion on Biological Therapy, Vol. 4, No. 8, 01.08.2004, p. 1203-1212.

Research output: Contribution to journalReview article

Pawar, Rajendra ; Ben-Ari, Alon ; Domb, Abraham J. / Protein and peptide parenteral controlled delivery. In: Expert Opinion on Biological Therapy. 2004 ; Vol. 4, No. 8. pp. 1203-1212.
@article{9d8b8f2a009d42cf8e154cb90e5fab0b,
title = "Protein and peptide parenteral controlled delivery",
abstract = "Protein and peptide delivery has been a challenge due to their limited stability during preparation of formulation, storage and in vitro and in vivo release. These biopolymers have traditionally been administered via intramuscular or subcutaneous routes. Recent efforts have been made to develop formulations for non-invasive routes of administration, including oral, intranasal, transdermal and transmucosal delivery. Despite these efforts, invasive delivery remains the main method of administering peptide and protein drugs. This review focuses on recent developments in injectable, polymeric controlled-release formulations, with an emphasis on hydrogels and particulate systems.",
keywords = "Controlled-release, Injectable particles, Invasive delivery, Peptide delivery, Protein delivery",
author = "Rajendra Pawar and Alon Ben-Ari and Domb, {Abraham J.}",
year = "2004",
month = "8",
day = "1",
doi = "10.1517/14712598.4.8.1203",
language = "English (US)",
volume = "4",
pages = "1203--1212",
journal = "Expert Opinion on Biological Therapy",
issn = "1471-2598",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Protein and peptide parenteral controlled delivery

AU - Pawar, Rajendra

AU - Ben-Ari, Alon

AU - Domb, Abraham J.

PY - 2004/8/1

Y1 - 2004/8/1

N2 - Protein and peptide delivery has been a challenge due to their limited stability during preparation of formulation, storage and in vitro and in vivo release. These biopolymers have traditionally been administered via intramuscular or subcutaneous routes. Recent efforts have been made to develop formulations for non-invasive routes of administration, including oral, intranasal, transdermal and transmucosal delivery. Despite these efforts, invasive delivery remains the main method of administering peptide and protein drugs. This review focuses on recent developments in injectable, polymeric controlled-release formulations, with an emphasis on hydrogels and particulate systems.

AB - Protein and peptide delivery has been a challenge due to their limited stability during preparation of formulation, storage and in vitro and in vivo release. These biopolymers have traditionally been administered via intramuscular or subcutaneous routes. Recent efforts have been made to develop formulations for non-invasive routes of administration, including oral, intranasal, transdermal and transmucosal delivery. Despite these efforts, invasive delivery remains the main method of administering peptide and protein drugs. This review focuses on recent developments in injectable, polymeric controlled-release formulations, with an emphasis on hydrogels and particulate systems.

KW - Controlled-release

KW - Injectable particles

KW - Invasive delivery

KW - Peptide delivery

KW - Protein delivery

UR - http://www.scopus.com/inward/record.url?scp=3442879344&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3442879344&partnerID=8YFLogxK

U2 - 10.1517/14712598.4.8.1203

DO - 10.1517/14712598.4.8.1203

M3 - Review article

C2 - 15268656

AN - SCOPUS:3442879344

VL - 4

SP - 1203

EP - 1212

JO - Expert Opinion on Biological Therapy

JF - Expert Opinion on Biological Therapy

SN - 1471-2598

IS - 8

ER -